Every finding on record at Absolute Hospice, Inc.

Upon patient record review, 12 of 19 (Patients #1, 2, 3, 5, 6, 7, 8, 9, 14, 15, 18, 19) did not have evidence in the patient record that a review was completed of all prescription and non-prescription medications, including herbal remedies that could affect drug therapy. This review includes, but is not limited to: • Effectiveness of drug therapy • Drug side effects • Actual or potential drug interactions • Duplicate drug therapy • Drug therapy currently associated with laboratory monitoring Patients #1,3,9: The medication profile includes order for Morphine 10-20 mg with no indicator for dosing mild/moderate/severe pain and Miralax 17g powder with no diluent. Corrected on Site. Patients#2,5,7,8,14,15,19: The medication profile includes order for Morphine 10-20 mg with no indicator for dosing mild/moderate/severe pain. Corrected on Site. Patient#18: The medication profile includes order Miralax 17g powder with no diluent. Corrected on Site.

Upon patient client record review, 8 of 19 (Patients #3, 5, 6, 8, 9, 12, 15, 19) did not have evidence that all entries are legible, clear, complete, and appropriately authenticated and dated in accordance with the organizations policies and procedures and currently accepted standards of practice. Electronic signatures are acceptable as long the hospice is following appropriate safeguards to prevent unauthorized access to the patient records Patient #3: The EOB form was scribbled out on SOC Date and blue ink correction. Not following Policies and Procedures (No2-009.2) for correcting mistaken entries and using black ink. Patients #5, 6, 8, 9,12,15,19: The EOB form had blue ink entries, not black ink as indicated in agency Policies and Procedures (No2-009.2).